Humanized antibodies are provided that specifically bind HLA-DR. The antibodies recognize the epitope recognized by the murine monoclonal antibody L243. Processes for preparing such antibodies, pharmaceutical compositions containing such antibodies, and clinical therapuetic and diagnostic, as well as research-related uses for such antibodies, are provided.
申请公布号
WO2006094192(A2)
申请公布日期
2006.09.08
申请号
WO2006US07598
申请日期
2006.03.03
申请人
IMMUNOMEDICS, INC.;GOLDENBERG, DAVID, M.;HANSEN, HANS, J.;QU, ZHENGXING;CHANG, CHEN-HSING
发明人
GOLDENBERG, DAVID, M.;HANSEN, HANS, J.;QU, ZHENGXING;CHANG, CHEN-HSING